Patients may only receive retatrutide through: Approved clinical trials registered with the MHRA and listed on the ISRCTN or ClinicalTrials.gov registries The MHRA Early Access to Medicines Scheme (EAMS) or compassionate use programmes, which allow access to promising unlicensed medicines for patients with serious conditions where no adequate alternative exists however, no such route is currently in place for retatrutide , and patients should not assume access is available outside of a formal trial It is strongly advised that patients do not attempt to source retatrutide through unregulated online pharmacies or grey-market suppliers
Some of the most common or potential side effects include: Nausea Constipation Vomiting Diarrhea Abdominal Pain Headache Indigestion Dizziness Back pain Increased Lipase or Amylase Altered taste Nasopharyngitis (common cold) Passing Gas Bloating Belching Gastroenteritis Decreased appetite Fatigue Gastroesophageal reflux disease Low blood sugar (hypoglycemia) in those with Type 2 diabetes Upset stomach These symptoms often subside as your body adjusts to the medications
Final thoughts: Retatrutide vs Mounjaro Retatrutide vs Mounjaro is a useful comparison, but only when the difference between the two is kept clear
Others need grab-and-go options because cooking feels overwhelming
The effects of GLP-1 therapies extend well beyond pharmacological appetite suppression
Alcohol can worsen dehydration during hot weather, and some semaglutide side effects like dizziness and fatigue may intensify in the heat
